Alva Health Wins $500,000 in R&D Funding from the U.S. National Science Foundation
DALLAS, TX, UNITED STATES, June 12, 2025 /EINPresswire.com/ — Alva Health, a medical device company pioneering wearable solutions for early stroke detection, has been awarded $500,000 from the U.S. National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase IIB program to conduct research and development on the company’s flagship product: a discreet, wrist-worn system designed to detect stroke symptoms in real time and enable faster access to emergency care.
Stroke remains a leading cause of death and long-term disability, with over 795,000 strokes and 240,000 Transient Ischemic Attacks, also known as mini-strokes, occurring annually in the United States according to the American Heart Association. By continuously monitoring physiological motor asymmetry — a key early indicator of stroke — the AI/ML enabled wearable device alerts caregivers and emergency responders within moments of symptom onset.
